ArticleAnnals of nuclear medicine2026

Radium-223 therapy in metastatic castration-resistant prostate cancer: baseline predictors of treatment completion and survival in a reimbursement-regulated Taiwanese cohort.

Hsi-Chen Tsai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.